Clinical Trials 0 COMMENT 49 Views Cantargia reports positive results Malin Otmani December 10, 2018 All patients in the company’s …
Clinical Trials 0 COMMENT 104 Views Nordic Nanovector presents new results Malin Otmani December 5, 2018 Nordic Nanovector announces that updated …
Clinical Trials 0 COMMENT 96 Views BerGenBio reports new results Malin Otmani December 5, 2018 The company has presented a …
Clinical Trials 290 Views LIDDS speeds up enrollment in phase IIb study Malin Otmani November 21, 2018 LIDDS adds two major university …
Clinical Trials 356 Views Green light for A1M Pharma’s Phase I study Malin Otmani November 12, 2018 A1M Pharma announces that the …
Clinical Trials 292 Views Pila Pharma announces new data Malin Otmani November 8, 2018 The company announces that the …
Clinical Trials 278 Views Positive results from ExpreS2ion Malin Otmani November 7, 2018 Swedish ExpreS2ion Biotech Holding AB …
Clinical Trials 252 Views Bavarian Nordic initiates Phase 2 trial Malin Otmani November 7, 2018 The first patient has been …
Clinical Trials 239 Views First patient dosed in Nordic Nanovector study Malin Otmani November 7, 2018 The company announces that the …
Clinical Trials 210 Views Bavarian Nordic initiates new clinical trial Malin Otmani November 7, 2018 The new trial evaluates the …
Clinical Trials 240 Views Negative update on Lundbeck’s Schizophrenia trial Malin Otmani October 31, 2018 The company has announced that DAYBREAKi, …
Clinical Trials 289 Views Headline results from Novo Nordisk’s PIONEER 8 trial Malin Otmani October 31, 2018 The company has announced results …
Clinical Trials 398 Views Phase III results from AstraZeneca Malin Otmani October 31, 2018 The company has presented results …
Clinical Trials 234 Views Orion and Bayer have completed phase III trial Malin Otmani October 26, 2018 The two companies have completed …
Clinical Trials 199 Views Nordic Nanovector opens first US site for its Paradigme trial Malin Otmani October 26, 2018 Nordic Nanovector announces that the …
Clinical Trials 204 Views Phase III trial results from AstraZeneca Malin Otmani October 23, 2018 AstraZeneca and Merck & Co. …
